Table 1.

Demographic and clinical characteristics of patients with PsA included in the study. Data expressed as mean ± SD, unless otherwise indicated.

VariablesDMARDAnti-TNF Agents
Number322296
Female, n (%)199 (62)178 (60)
Age, yrs57.2 ± 12.447.5 ± 22.5
Smokers, n109103
Familial history of malignancies, n (%)47 (15)151 (51)
Incidence of malignancies (%)9.34.7
TJC19.5 ± 4.516.8 ± 7.1
SJC3.2 ± 2.22.1 ± 1.9
PASI6.7 ± 3.94.9 ± 2.6
HAQ2.1 ± 1.11.9 ± 0.5
Patient pain score64.3 ± 18.361.1 ± 13.5
Tender entheseal count7.2 ± 3.16.5 ± 2.2
  • PsA: psoriatic arthritis; DMARD: disease-modifying antirheumatic drugs; TNF: tumor necrosis factor; TJC: tender joint count; SJC: swollen joint count; PASI: Psoriasis Area and Severity Index; HAQ: Health Assessment Questionnaire.